Aspire2B Personalization Pilot Study Program
Completed · Not applicable
Conditions studied: App Proficiency, Behavior, Lifestyle
In brief
This non-randomized pilot study program is focused on assessing the technical characteristics of the Aspire2B mobile device application.
Key facts
- Study ID
- NCT06191822
- Run by
- PepsiCo Global R&D
- People needed
- 1714
- Starts
- 2022-03-01
- Expected to finish
- 2023-09-01
- Last updated by the study team
- 2026-06-05
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Fluent in reading and understanding English or Spanish
- Smartphone users
You may not qualify if…
- Cannot proceed to onboarding without downloading the app, consenting to participate, and agreeing to app Terms of Use
Where it is running
- Remote, no facility visits. Managed by PepsiCo R&D Life Sciences — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.